SynAct Pharma AB (STO:SYNACT)
Sweden flag Sweden · Delayed Price · Currency is SEK
15.96
-0.26 (-1.60%)
Nov 2, 2026, 5:24 PM CET

SynAct Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8941,2054173142,4163,703
Market Cap Growth
-21.32%189.20%32.69%-87.00%-34.75%242.52%
Enterprise Value
8801,1293802862,3643,659
Last Close Price
16.2222.608.968.7580.76140.30

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
5.297.081.951.7819.10177.45
P/TBV Ratio
5.297.081.951.7819.10177.45

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.010.000.020.15
Net Debt / Equity Ratio
-0.08-0.31-0.28-0.35-0.84-1.00
Net Debt / EBITDA Ratio
-0.453.930.82--
Quick Ratio
4.943.102.663.008.192.25
Current Ratio
5.693.323.303.019.342.27
Return on Equity (ROE)
-57.67%-57.65%-42.22%-142.59%-134.62%-377.30%
Return on Assets (ROA)
-31.25%-29.60%-22.48%-50.54%-72.92%-159.60%
Return on Capital Employed (ROCE)
-56.10%-58.40%-37.00%-73.80%-82.70%-333.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-12.31%-9.20%-19.77%-68.71%-4.11%-1.87%
Buyback Yield / Dilution
-19.07%-28.94%-21.81%-17.90%-6.72%-19.95%